Seung-Uk Lee1,2, Ji-Eun Lee3,4, Su-Jin Kim5, Jong-Soo Lee6,7. 1. Department of Ophthalmology, College of Medicine, Kosin University, Busan, Korea. 2. Department of Ophthalmology, Kosin University Gospel Hospital, Busan, Korea. 3. Department of Ophthalmology, School of Medicine, Pusan National University, Busan, Korea. 4. Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Korea. 5. Department of Ophthalmology, School of Medicine, Gyeongsang National University, Gyeongsang National University Changwon Hospital, Changwon, Korea. 6. Department of Ophthalmology, School of Medicine, Pusan National University, Busan, Korea. jongsool@pusan.ac.kr. 7. Medical Research Institute, Pusan National University Hospital, Busan, Korea. jongsool@pusan.ac.kr.
Abstract
PURPOSE: To investigate the effect of titanium dioxide (TiO2) nanoparticles on the inhibition of the in vitro cellular activity of human Tenon's fibroblasts (HTFs) under UVA exposure. METHODS: The effects of TiO2 nanoparticles on human Tenon's fibroblasts were evaluated after 1, 4, 6, and 24 h of exposure to UVA at levels of 2.5, 5.0, and 10 J/cm2. The methyl thiazolyl tetrazolium (MTT) assay was performed to measure the suppression of cellular metabolic activity. The lactate dehydrogenase (LDH) assay was performed to determine the extent of cell membrane damage. Flow cytometric analysis and inverted phase-contrast and electron microscopy were performed. The scratch wound assay was performed to visualize suppression of cellular migration. RESULTS: MTT assay values were similar between the UVA-exposed groups and the control group without UVA exposure. However, the combined exposure of TiO2 nanoparticles and UVA exposure induced significant dose-dependent inhibition of cellular viability and damage to HTFs, especially at concentrations of TiO2 equal to or greater than 100 μg/mL and 2.5 J/cm2 of UVA irradiation. Changes in cellular morphology increased in a dose-dependent pattern with a TiO2 concentration greater than 100 μg/mL under UVA exposure. At a TiO2 concentration of 150 μg/mL, damage to the cellular morphology of the HTFs was significantly increased, and nanoparticles were seen inside of the cytoplasm in the affected HTFs exposed to UVA. There was a significant reduction of cellular migration at TiO2 concentrations higher than 150 μg/mL. CONCLUSION: TiO2 nanoparticles inhibited the cellular activity of HTFs under UVA irradiation and showed potential for use to prevent the wound scarring of Tenon's fibroblasts. Further studies will be necessary to determine the optimal concentration of TiO2 nanoparticles and UVA exposure dose for clinical applications.
PURPOSE: To investigate the effect of titanium dioxide (TiO2) nanoparticles on the inhibition of the in vitro cellular activity of human Tenon's fibroblasts (HTFs) under UVA exposure. METHODS: The effects of TiO2 nanoparticles on human Tenon's fibroblasts were evaluated after 1, 4, 6, and 24 h of exposure to UVA at levels of 2.5, 5.0, and 10 J/cm2. The methyl thiazolyl tetrazolium (MTT) assay was performed to measure the suppression of cellular metabolic activity. The lactate dehydrogenase (LDH) assay was performed to determine the extent of cell membrane damage. Flow cytometric analysis and inverted phase-contrast and electron microscopy were performed. The scratch wound assay was performed to visualize suppression of cellular migration. RESULTS:MTT assay values were similar between the UVA-exposed groups and the control group without UVA exposure. However, the combined exposure of TiO2 nanoparticles and UVA exposure induced significant dose-dependent inhibition of cellular viability and damage to HTFs, especially at concentrations of TiO2 equal to or greater than 100 μg/mL and 2.5 J/cm2 of UVA irradiation. Changes in cellular morphology increased in a dose-dependent pattern with a TiO2 concentration greater than 100 μg/mL under UVA exposure. At a TiO2 concentration of 150 μg/mL, damage to the cellular morphology of the HTFs was significantly increased, and nanoparticles were seen inside of the cytoplasm in the affected HTFs exposed to UVA. There was a significant reduction of cellular migration at TiO2 concentrations higher than 150 μg/mL. CONCLUSION:TiO2 nanoparticles inhibited the cellular activity of HTFs under UVA irradiation and showed potential for use to prevent the wound scarring of Tenon's fibroblasts. Further studies will be necessary to determine the optimal concentration of TiO2 nanoparticles and UVA exposure dose for clinical applications.
Entities:
Keywords:
Human Tenon’s fibroblasts; Titanium dioxide nanoparticles; UVA
Authors: Kristen Sanders; Laura L Degn; William R Mundy; Robert M Zucker; Kevin Dreher; Baozhong Zhao; Joan E Roberts; William K Boyes Journal: Toxicol Appl Pharmacol Date: 2011-11-15 Impact factor: 4.219
Authors: Jun-Jie Yin; Jun Liu; Marilyn Ehrenshaft; Joan E Roberts; Peter P Fu; Ronald P Mason; Baozhong Zhao Journal: Toxicol Appl Pharmacol Date: 2012-06-13 Impact factor: 4.219
Authors: E J Higginbotham; R K Stevens; D C Musch; K O Karp; P R Lichter; T J Bergstrom; G L Skuta Journal: Ophthalmology Date: 1996-04 Impact factor: 12.079
Authors: Patricia Brassolatti; Joice Margareth de Almeida Rodolpho; Krissia Franco de Godoy; Cynthia Aparecida de Castro; Genoveva Lourdes Flores Luna; Bruna Dias de Lima Fragelli; Matheus Pedrino; Marcelo Assis; Marcel Nani Leite; Juliana Cancino-Bernardi; Carlos Speglich; Marco Andrey Frade; Fernanda de Freitas Anibal Journal: Int J Nanomedicine Date: 2022-03-30